CytoMed Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.About GDTC
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments.
CEOWee Kiat Tan, PhD
CEOWee Kiat Tan, PhD
Employees43
Employees43
HeadquartersSingapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded2018
Founded2018
Employees43
Employees43
GDTC Key Statistics
Market cap18.77M
Market cap18.77M
Price-Earnings ratio-6.66
Price-Earnings ratio-6.66
Dividend yield—
Dividend yield—
Average volume56.35K
Average volume56.35K
High today$1.66
High today$1.66
Low today$1.58
Low today$1.58
Open price$1.62
Open price$1.62
Volume14.70K
Volume14.70K
52 Week high$4.05
52 Week high$4.05
52 Week low$1.50
52 Week low$1.50
Stock Snapshot
The current CytoMed Therapeutics(GDTC) stock price is $1.58, with a market capitalization of 18.77M. The stock trades at a price-to-earnings (P/E) ratio of -6.66.
On 2025-12-16, CytoMed Therapeutics(GDTC) stock moved within a range of $1.58 to $1.66. With shares now at $1.58, the stock is trading 0.0% above its intraday low and -4.8% below the session's peak.
Trading volume for CytoMed Therapeutics(GDTC) stock has reached 14.7K, versus its average volume of 56.35K.
The stock's 52-week range extends from a low of $1.50 to a high of $4.05.
The stock's 52-week range extends from a low of $1.50 to a high of $4.05.
People also own
Based on the portfolios of people who own GDTC. This list is generated using Robinhood data, and it’s not a recommendation.